The Efficacy of Platelets Rich Plasma Injection in the Superior Joint Space of the Tempromandibular Joint Guided by Ultra Sound in Patients with Non-reducing Disk Displacement
- PMID: 28286383
- PMCID: PMC5328864
- DOI: 10.1007/s12663-016-0911-9
The Efficacy of Platelets Rich Plasma Injection in the Superior Joint Space of the Tempromandibular Joint Guided by Ultra Sound in Patients with Non-reducing Disk Displacement
Abstract
Objective: The objective of this study was to determine average improvement during the rest and active mouth opening after ultrasound guided platelets rich plasma injection in the tempromandibular superior joint space for the patients complaining from non-reducing disk displacement.
Patients and methods: Thirty-four patients with non-reducing disk displacement underwent guided ultrasound injection of platelet rich plasma to the upper joint space. The extent of maximal mouth opening, chewing efficiency, sound intensity of the TMJ, and tenderness of the TMJ and the masticatory muscles at rest, motion and mastication were thoroughly assessed at the beginning of the study and scheduled for next follow-up at 1st, 3rd, and 6th months.
Results: Injection with platelets rich plasma was significantly more effective in improvements of the extent of maximal mouth opening, statistics result demonstrated a significant reduction in the VAS values of pain at rest, motion and mastication compared to the baseline VAS values.
Conclusion: PRP injection to the upper temporomandibular joint space provided improvement in signs and symptoms of patient with non-reducing disk displacement of the temporomandibular joint.
Keywords: Clinical outcome; Non-reducing disk displacement; Platelets rich plasma; Risk factor; Superior joint space; Temporomandibular joint.
Conflict of interest statement
Conflict of interest
All the authors declare that they have no conflict of interest.
Ethical Standard
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed Consent
Informed consent was obtained from all individual participants included in the study.
References
-
- Lee K, Chow J, Hui E, Li W. Botulinum toxin type A injection for the management of myofascial temporomandibular pain disorder botulinum toxin for myofascial temporomandibula Asian. J Oral Maxillofac Surg. 2005;17(2):100–101.
-
- American Dental Association Report of the President’s conference on the examination, diagnosis and management of temporomandibular disorders. J Am Dent Assoc. 1988;66:75. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials